Bill
Bill > SB399
NH SB399
NH SB399Relative to insurance coverage for blood testing associated with elevated lead levels.
summary
Introduced
12/12/2023
12/12/2023
In Committee
05/15/2024
05/15/2024
Crossed Over
02/29/2024
02/29/2024
Passed
06/25/2024
06/25/2024
Dead
Signed/Enacted/Adopted
07/10/2024
07/10/2024
Introduced Session
2024 Regular Session
Bill Summary
This bill provides that health insurance coverage for blood lead testing shall not be subject to a co-payment, deductible, or coinsurance. The bill also requires coverage for follow-up blood testing that is necessary to complete the preventive screening when the initial blood testing indicates an elevated blood lead level or is inconclusive.
AI Summary
This bill provides that health insurance coverage for blood lead testing shall not be subject to a co-payment, deductible, or coinsurance. The bill also requires coverage for follow-up blood testing that is necessary to complete the preventive screening when the initial blood lead testing indicates an elevated blood lead level or is inconclusive. This is intended to promote lead poisoning prevention and treatment.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (13)
Regina Birdsell (R)*,
Kevin Avard (R),
Jeb Bradley (R),
Anita Burroughs (D),
Shannon Chandley (D),
Dan Innis (R),
John Potucek (R),
Denise Ricciardi (R),
Cindy Rosenwald (D),
Donna Soucy (D),
Jared Sullivan (D),
Dick Thackston (R),
Becky Whitley (D),
Last Action
Signed by the Governor on 07/03/2024; Chapter 0156; Effective 09/01/2024 (on 07/10/2024)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...